Hrt Financial LP Oragenics Inc Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.23 - $14.18 $2,924 - $180,327
12,717 New
12,717 $2,000
Q4 2021

Feb 14, 2022
SELL
$0.43 - $0.69 $7,417 - $11,902
-17,250 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$0.58 - $0.84 $10,005 - $14,490
17,250 New
17,250 $10,000
Q4 2020

Feb 16, 2021
SELL
$0.39 - $0.6 $15,646 - $24,071
-40,119 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$0.56 - $1.49 $22,466 - $59,777
40,119 New
40,119 $22,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $36.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email